Pushing Canadian HIV/AIDS research further (B.C. Centre for Excellence in HIV/AIDS)
A one-of-a-kind national HIV/AIDS study, led by Simon Fraser University health scientist Robert Hogg, is getting new funding to expand its mandate.
Over the next five years, the Canadian Institutes of Health Research will inject $2.7 million into the Canadian Observational Cohort (CANOC). It is the country’s only longitudinal study of more than 10,000 HIV-positive individuals receiving antiretroviral therapy (ART) in Canada.
In his role as a research scientist with B.C. Centre for Excellence in HIV/AIDS, Hogg has been overseeing CANOC’s exploration of ART’s efficacy in B.C., Ontario and Quebec since 2008, when the network was created.
Dr. Scott MacDonald, Providence Crosstown Clinic